Local delivery of CER-001 in advanced plaques Proof-of-concept for apoA-1 as initiator of reverse cholesterol transport (LOCATION)

Trial Profile

Local delivery of CER-001 in advanced plaques Proof-of-concept for apoA-1 as initiator of reverse cholesterol transport (LOCATION)

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2017

At a glance

  • Drugs CER 001 (Primary)
  • Indications Hypoalphalipoproteinaemia
  • Focus Proof of concept; Therapeutic Use
  • Acronyms LOCATION
  • Most Recent Events

    • 12 Mar 2016 Status changed from active, no longer recruiting to completed.
    • 15 Jul 2015 Status changed from recruiting to active, no longer recruiting, based on information in Cerenis Therapeutics media release.
    • 15 Jul 2015 Results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top